1 / 21

INSULIN

BIOCHEMISTRY

mprasadnaidu
Download Presentation

INSULIN

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Insulin & oral hypoglycaemic M.Prasad Naidu MSc Medical Biochemistry, Ph.D,.

  2. Diabetes mellitus :- It is a group of heterogenous disorder in which carbohydrate metabolism is ↓, while that of proteins & lipids are ↑. Types :- Type I - insulin dependent DM Type II – non insulin dependent DM Type III – DM occurs by other disorders Type IV – gestational DM

  3. Insulin :- Chemistry , biosynthesis & secretion :- Chemistry : - Insulin is made up of 86 aminoacids , It contain A chain – 21 AA, B chain – 30 AA, Connecitng Peptide – 35 AA. Biosynthesis :- Preproinsulinproinsulin Insulin + C peptide Secretion :- Glucose transport to β cell by GLUT 2 glucose transporter, it undergoes further metabolism, it generated ATP. Which inhibit the activity of K+ CHANNELS. The inhibition of K+ channel induces β cell membrane depolarisation, opening of voltage dependent Ca2+ channel & stimulates insulin secretion.

  4. Pharmacological actions :- • Carbohydrate metabolism : • ↑glycogenesis ↓ glycogenolysis • Protein metabolism : • ↓ protein break down ↑ • Fat metabolism : • ↑ lipogenesis ↑fatty acid synthesis.

  5. Newer insulin preparations : • Insulin syringes • Portable pen injections • Insulin pumps • Biodegradable microspheres • Inhaled insulins • Therapeutic uses :- • Type 1 diabetes – NPH + Regular Insulin • Type 2 diabetes - Regular Insulin • Diabetic ketoacidosis – Tr. IV fluids, Kcl, sodium bicarbonate, phoshate • Non ketonic hyperglycemic • Emergency treatment of hyperkalaemia

  6. Adverse effects :- • Hypoglycaemia • Lipodystrophy • Allergic manifestation • Insulin resistance • Edema

  7. Oral hypoglycaemic drugs :- Classification :- Sulfonylureas : 1st generation - Tolbutamide Chlorpropamide 2nd generation – Glibenclamide Glipizide Gliclazide Glimepiride Meglitinide analogues :- Repaglinide Nateglinide

  8. Biguanides :- Metformin Phenformin Alfa glucosidase inhibitors :- Acarbose Miglitol Thiazolidinediones : Rosiglitazone Pioglitazone

  9. Sulfonylureas :- MOA :- Sulfonylureas acts on beta cells, stimulating insulin secretion and thus reducing blood glucose levels. Drugs reuce the permeability of K+ by competitively blocking the sulfonylureas receptors present on ATP sensitive K+ channels , causing depolarisation, Ca2+ entry and insulin secretion. Adverse effects :- Hypoglycaemia Weight gain, nausea, vomiting, diarrhoea, constipation , agranulocytosis, hypersensitivity, cholestatic jaundice.

  10. PK :- Absorbed orally, high plasma protein bindint(90-98%) Metabolized in liver , excreted in urine Duration of action – 6-12 hr It croses placental barrier it caused hypoglycaemia at birth CI :- Pregnancy Gestational diabetes

  11. Drug interactions :- Drugs that potentiate the effects of sulfonylureas– Oral anticoagulants, ketoconazole, chloramphenicol (-) metabolism Salicylates, sulfonamides , clofibrate – displace protein binding sites Drugs that decrease the effects of sulfonylurease: Phenobarbitone, phenytoin , rifampicin – decrease metabolism corticosteroids, thiadides, estrogens - Biguanides :- ↑ uptake and utilization of glucose in skeletal muscle reduce insulin resistant (-) renal hepatic gluconeogenesis ↓ glucose absorption from GIT ↓ Plasma glucagon levels

  12. Corticosteroids Classification :- Glucocorticoids : Short acting – Hydrocortisone Intermediate acting – Prednisolone Methyl prednisolone Triamcinolone Long acting - Betamethasone Dexamethasone Meneralocorticoids :- Desoxycorticosterone acetate Fludrocortisone aldosterone

  13. Mechanism of actions :- Corticoids bind to specific receptor in the cytoplasm , the drug Receptor complex is transported into the nucleous where it binds to specific Sites on DNA and regulates the synthesis of new proteins that bring about The hormone effects . Pharmacological actions :- Mineralocorticoids highly effects on Na+, k+ and fluid balance Glucocorticoids highly effects on carbohydrate, protein, fat and other. Metabolic effects :- Carbohydrate – promote gluconeogenesis Protein- enhance protein break down Fat –lipolysis, redistribution of fat

  14. Antiinflammatory and immunosuppressive effects :- • Supress development of inflammatory response to all types of stimuli inhibit bothLate and early manifestations of inflammation. • Supress cell mediated immunity, prevent manifestations of allergy • Ca 2+ metabolism – (-) intestinal absorption & enhance renal excretion of ca2+ • CVS :- • Skeletal muscle :- hypocritism, hypercritism • CNS :- euphoria • Stomach :- increase gastric secretion • Lymphoid tissue and blood cells :- increase destruction of lymphoid cells, increase no. of RBC, neutrophils, platelets.

  15. Therapeutic uses :- • Replacement therapy : • Acute adrenal insufficiency • Chronic adrenal insufficiency • Congenital adrenal hyperplasia • Pharmacotherapy: • Arthritides : NSAIDS + glucocorticoids • Rheumatoid arthritis • Osteoarthritis • Rheumatic fever • Gout • Collagen diseases – SLE, nephrotic syndrome, glomerulonethritis • Severe allergic reactions – angioneuotic edema, urticaria and serum sickness

  16. Autoimmune diseases : haemolyticanaemia, thrombocytopenia, • chronic hepatitis • Bronchial asthma : status asthmaticus, acute asthma excerbation • Other lung diseases : Pulmonary edema aspiration penumonia • Infective diseases : tuberculosis, severe lepra reaction • Eye diseases : keratitis, iridocyclitis, iritis, allergic conjuctivitis, prevent blindness • Skin diseases : exfoliative dermatitis, stevenshohnson syndrome • Intestinal diseases : ulcerative colitis, coeliac disease • Cerebral edema : • Malignancies : acute lymphatic leukemia, hodgkins & breast carcinoma • Organ transplantation and skin allograft : liver, kidney, heart transplantation. • Shock :

  17. Adverse effects :- • Mineralocorticoids– hypokalemic alkalosis, edema, raise in BP • Glucocorticoids :- • Cushing’s habitus • Hyperglycaemia • Muscular weakness • Delayed healing • Peptic ulceration • Osteoporosis • Galucoma • Growth retardation • Foetal abnormalities

  18. Psychiatric disturbances • Suppression of hypothalamo pituitary adrenal axis • Fragile skin , purple striae • Contraindications :- • Peptic ulcer • DM • HT • Viral and fungal infections • Tuberculosis & other infections • Osteoporosis • Psychosis • Epilepsy • CHF • Renal failure

  19. THANK U

More Related